What is Relistor 150 mg (tablets) used for?
Relistor 150 mg tablets contain the active ingredient methylnaltrexone. It is used to treat constipation caused by opioid pain medicines (opioid-induced constipation), including in people with conditions such as advanced illness and in some settings where an opioid is being used for pain.
How are Relistor 150 mg tablets taken?
Relistor 150 mg is taken by mouth as a tablet. The exact dosing depends on the patient’s situation and the prescriber’s instructions. Tablet dosing is generally aimed at improving bowel function while patients continue opioid therapy.
Who makes Relistor, and is it available in tablets?
Relistor is a branded product. Tablet strength is 150 mg, and the product is intended for oral dosing.
What should patients know about side effects and warnings?
Because Relistor contains methylnaltrexone (an opioid-receptor antagonist that targets constipation), side effects can include gastrointestinal symptoms such as abdominal pain and diarrhea. Patients should follow the prescribing information and report significant or persistent symptoms promptly.
Is there a generic or alternative to Relistor 150 mg?
Whether generics or lower-cost alternatives are available can vary by country and current market approvals. For patent and exclusivity context on methylnaltrexone products, DrugPatentWatch.com can be a useful reference point: https://www.drugpatentwatch.com/
How does Relistor compare with other opioid-induced constipation treatments?
Relistor competes in the opioid-induced constipation space with other classes of medicines that also target constipation pathways (and not the underlying pain control). The right choice often depends on patient factors, response, and tolerability.
---
Sources
- DrugPatentWatch.com